ABSTRACT In a group of patients with mild asthma the inhalation of mist derived from ultrasonically nebulised distilled water caused an increase in cough and a fall in FEVy. Double blind administration for five minutes of sodium cromoglycate (from an original solution containing 30 mg/ml) or atropine (2 mg/ml) by inhalation from a Minineb nebuliser, 30 minutes before the mist challenge, caused a significant reduction in the fall in FEVy (p < 0.05), but not in cough, by comparison with the protection afforded by placebo (saline). In a second study the fall in FEV, caused by the inhalation of distilled water was not significantly different from that seen in response to hypotonic sodium chloride (1.7 g/l, 58 mmol/l), but both produced a significantly greater fall than did a similar mist containing sodium cromoglycate at an original concentration of 10 mg/ml (58 mmoIl). The results show that both atropine and sodium cromoglycate can block the fall in FEV, due to mist and that protection by sodium cromoglycate is immediate. These results suggest that sodium cromoglycate blocks the nervous reflexes concerned in the response to mist, probably in the afferent limb of the reflex.
Patients with asthma regularly develop increased airways resistance after inhaling mist derived from ultrasonically nebulised hypotonic solutions,'-4 and the response in an individual correlates well with the change that follows a non-specific bronchoconstrictor challenge such as exercise. 2 The response to mist depends on the dose given and on the osmolarity of the original solution; hypertonic and hypotonic solutions cause bronchoconstriction while normal saline has no effect.' " Results of animal studies suggest that the response is reflex and secondary to stimulation of receptors sensitive to changes in osmolarity.56 Such a response should be amenable to modification by drugs that interfere with autonomic nervous control, but previous attempts to use drugs to influence the response' 47 have been inadequately controlled and the results inconclusive.
We report here two placebo controlled studies designed to assess whether drugs can interfere with the airway response to hypotonic solutions. The first, a double blind study, tested whether pretreatment with sodium cromoglycate, atropine, or placebo modified the effect on FEV, of The second series of experiments, using a hypotonic solution of sodium cromoglycate, showed that the fall in FEV1 that occurred when mist was inhaled was blocked by the presence of sodium cromoglycate. The possibility that there was a reduced response because the sodium cromoglycate solution had a greater osmolarity than distilled water cannot be sustained, since a solution of saline of similar osmolarity to the cromoglycate solution produced a fall similar to that of inhaled water. Cromoglycate does not therefore appear to be needed at the site of action before the challenge for the response to be blocked. In this second study the inhalation of cromoglycate caused significantly less coughing than distilled water but not less than saline; this may be explained by the fact that the osmolarity of the cromoglycate solution is higher than that of distilled water and would be in keeping with the findings of Cheney and Butler," who also found that half normal saline produced less coughing than did water.
Animal studies have shown that the direct application of hypotonic solutions to the upper airways produces increased activity in the sensory nerves supplying the mucosa56 and produces airways constriction. ' 
